Cite
HARVARD Citation
Park, S. et al. (2022). 316.5: Long Term Outcomes of Low Dose Anti-thymocyte Globulin And Anti-interleukin-2 Receptor Antibody Induction in Kidney Transplantation From Expanded Criteria Donors. Transplantation. p. S245. [Online].